ArticleCurrent cancer drug targets2026

Evaluation of the Antitumoral Effect of PI3K/AKT/mTOR Pathway Inhibition and Antioxidant Combination on Burkitt Lymphoma Cell Line.

Ibrahim Karaduman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.